Nipro Corporation (8086.T) stock price, revenue, and financials

Nipro Corporation market cap is ¥166.7 b, and annual revenue was ¥442.52 b in FY 2020

View Company

¥166.7 B

8086.T Mkt cap, 27-May-2022

¥341.1 B

Nipro Corporation Revenue Q3, 2021

Nipro Corporation Gross profit (Q3, 2021)105.3 B

Nipro Corporation Gross profit margin (Q3, 2021), %30.9%

Nipro Corporation Net income (Q3, 2021)10.9 B

Nipro Corporation EBIT (Q3, 2021)23.1 B

Nipro Corporation Cash, 31-Dec-2020106 B

Nipro Corporation EV610.8 B

Nipro Corporation Revenue

Nipro Corporation revenue was ¥442.52 b in FY, 2020 which is a 3.8% year over year increase from the previous period.

Embed Graph

Nipro Corporation Revenue Breakdown

Embed Graph

Nipro Corporation revenue breakdown by business segment: 8.2% from PharmaPackaging, 15.9% from Pharmaceutical-Related, 75.9% from Medical-Related and 0.0% from Other

Nipro Corporation revenue breakdown by geographic segment: 13.5% from Asia, 60.5% from Japan, 11.5% from Europe and 14.5% from Americas

Annual

JPY	FY, 2018	FY, 2019	FY, 2020
Revenue	395.4b	426.4b	442.5b
Revenue growth, %		8%	4%
Cost of goods sold	268.3b	295.8b	308.3b
Gross profit	127.1b	130.6b	134.2b
Gross profit Margin, %	32%	31%	30%
General and administrative expense	100.0b	106.8b	107.8b
Operating expense total	100.0b	106.1b	107.8b
EBIT	27.1b	23.8b	26.4b
EBIT margin, %	7%	6%	6%
Interest expense	3.5b	3.3b	3.5b
Interest income	577.0m	816.0m	847.0m
Pre tax profit	17.0b	21.2b	(10.2b)
Income tax expense	4.7b	9.4b	1.4b
Net Income	12.3b	11.9b	(11.6b)
EPS	64.5	66.7

Quarterly

JPY	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2019	Q3, 2021
Revenue	103.2b	208.3b	321.3b	109.8b	222.7b	336.7b	108.9b	222.3b	341.1b
Cost of goods sold	69.6b	144.4b	222.1b	75.7b	155.9b	234.6b	75.2b	153.8b	235.8b
Gross profit	33.6b	63.9b	99.2b	34.0b	66.7b	102.1b	33.7b	68.4b	105.3b
Gross profit Margin, %	33%	31%	31%	31%	30%	30%	31%	31%	31%
General and administrative expense	26.1b	51.9b	78.8b	27.0b	53.9b	82.1b	26.8b	53.9b	105.3b
Operating expense total	26.1b	51.9b	78.8b	27.0b	53.9b	82.1b	26.8b	53.9b	105.3b
EBIT	7.5b	12.0b	20.4b	7.0b	12.8b	20.0b	6.9b	14.5b	23.1b
EBIT margin, %	7%	6%	6%	6%	6%	6%	6%	7%	7%
Interest expense	715.0m	1.5b	2.5b	932.0m	1.8b	2.7b	924.0m	1.9b	2.9b
Interest income	139.0m	339.0m	527.0m	183.0m	435.0m	605.0m	202.0m	383.0m	509.0m
Pre tax profit	8.3b	13.8b	18.0b	5.0b	9.9b	17.5b	5.8b	9.5b	17.8b
Income tax expense	3.6b	6.0b	8.0b	2.0b	3.8b	6.1b	2.5b	3.7b	6.9b
Net Income	4.7b	7.7b	10.0b	3.0b	6.2b	11.4b	3.3b	5.8b	10.9b

Annual

JPY	FY, 2018	FY, 2019	FY, 2020
Cash	141.9b	129.4b	95.9b
Accounts Receivable	140.5b	149.0b	152.5b
Inventories	129.2b	137.9b	153.3b
Current Assets	436.0b	443.0b	433.0b
PP&E	270.3b	284.5b	307.6b
Goodwill	27.4b	19.3b	14.7b
Total Assets	826.8b	845.8b	831.9b
Accounts Payable	62.1b	69.6b	69.5b
Short-term debt	130.1b	144.6b	165.1b
Current Liabilities	251.2b	274.3b	289.4b
Long-term debt	380.5b	385.5b	360.5b
Non-Current Liabilities	392.1b	399.7b	381.2b
Total Debt	510.6b	530.1b	525.6b
Total Liabilities	643.3b	674.0b	670.6b
Common Stock	84.4b	84.4b	84.4b
Additional Paid-in Capital			5.0m
Retained Earnings	83.6b	90.7b	74.8b
Total Equity	183.5b	171.8b	161.3b
Debt to Equity Ratio	2.8 x	3.1 x	3.3 x
Debt to Assets Ratio	0.6 x	0.6 x	0.6 x
Financial Leverage	4.5 x	4.9 x	5.2 x

Quarterly

JPY	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021	Q3, 2021
Cash	125.9b	143.6b	132.2b	108.4b	103.0b	92.0b	86.9b	120.2b	106.0b
Accounts Receivable	151.5b	144.0b	154.1b	151.1b	150.9b	160.7b	149.6b	151.5b	161.0b
Inventories	129.4b	133.3b	135.7b	141.1b	143.7b	146.2b	155.1b	161.9b	163.3b
Current Assets	417.7b	440.9b	444.8b	423.6b	422.0b	425.5b	422.9b	467.6b	433.0b
PP&E	268.5b	272.1b	280.9b	294.2b	295.0b	297.2b	321.6b	324.5b	329.6b
Goodwill	26.7b	26.2b	25.3b	18.6b	17.8b	17.6b	14.4b	14.3b	15.3b
Total Assets	810.9b	843.5b	845.9b	835.0b	832.7b	836.5b	836.4b	888.3b	884.1b
Accounts Payable	63.5b	66.7b	70.7b	69.8b	68.2b	68.8b	67.7b	70.5b	67.2b
Short-term debt	136.9b	147.3b	149.0b	153.6b	138.6b	131.4b	158.6b	183.8b	176.0b
Current Liabilities	247.1b	261.4b	274.3b	276.0b	261.8b	249.9b	279.1b	313.1b	306.2b
Long-term debt	374.1b	387.0b	387.2b	373.3b	387.5b	397.1b	361.4b	374.6b	374.1b
Non-Current Liabilities	385.0b	399.6b	400.3b	387.9b	404.2b	414.4b	400.0b	413.0b	412.1b
Total Debt	510.9b	534.3b	536.2b	526.9b	526.1b	528.5b	520.0b	558.4b	550.1b
Total Liabilities	632.1b	661.1b	674.5b	663.9b	666.1b	664.3b	679.1b	726.1b	718.4b
Common Stock	84.4b	84.4b	84.4b	84.4b	84.4b	84.4b	84.4b	84.4b	84.4b
Additional Paid-in Capital				1.0m	1.0m	1.0m	4.0m	4.0m	4.0m
Retained Earnings	86.4b	89.4b	88.5b	92.0b	95.1b	97.9b	77.8b	80.2b	83.3b
Total Equity	178.8b	182.4b	171.3b	165.6b	166.7b	172.2b	157.4b	162.2b	165.8b
Debt to Equity Ratio	2.9 x	2.9 x	3.1 x	3.2 x	3.2 x	3.1 x	3.3 x	3.4 x	3.3 x
Debt to Assets Ratio	0.6 x	0.6 x	0.6 x	0.6 x	0.6 x	0.6 x	0.6 x	0.6 x	0.6 x
Financial Leverage	4.5 x	4.6 x	4.9 x	5 x	5 x	4.9 x	5.3 x	5.5 x	5.3 x

Annual

JPY	FY, 2018	FY, 2019	FY, 2020
Net Income	12.3b	11.9b	(11.6b)
Depreciation and Amortization	38.2b	39.5b	47.5b
Accounts Receivable	(7.3b)	(12.3b)	(2.7b)
Inventories	(4.9b)	(11.4b)	(15.2b)
Accounts Payable	(3.8b)	11.8b	205.0m
Cash From Operating Activities	41.0b	41.4b	37.2b
Purchases of PP&E	(60.1b)	(56.0b)	(57.9b)
Cash From Investing Activities	(64.1b)	(64.7b)	(58.3b)
Short-term Borrowings	8.8b	(6.7b)	18.6b
Long-term Borrowings	(91.2b)	(70.9b)	(102.4b)
Dividends Paid	(6.5b)	(5.0b)	(3.8b)
Cash From Financing Activities	47.3b	12.6b	(4.6b)
Net Change in Cash	23.6b	(15.4b)	(30.2b)
Interest Paid	3.3b	3.2b	3.2b
Income Taxes Paid	7.3b	8.2b	9.1b

Half Year

JPY	H1, 2019	H1, 2020	H1, 2021
Net Income	7.7b	6.2b	5.8b
Depreciation and Amortization	18.2b	19.8b	19.8b
Accounts Receivable	(5.9b)	(3.2b)	(743.0m)
Inventories	(3.3b)	(6.8b)	(10.2b)
Accounts Payable	5.8b	(173.0m)	2.4b
Cash From Operating Activities	19.7b	15.3b	23.2b
Purchases of PP&E	(33.1b)	(30.6b)	(24.2b)
Cash From Investing Activities	(37.6b)	(35.2b)	(22.2b)
Short-term Borrowings	(5.5b)	16.5b	(10.9b)
Long-term Borrowings	(34.4b)	(56.1b)	(32.6b)
Dividends Paid	(1.9b)	(1.5b)	(53.0m)
Cash From Financing Activities	20.2b	(2.3b)	29.6b
Net Change in Cash	383.0m	(24.5b)	25.1b
Interest Paid	1.4b	1.7b	1.9b
Income Taxes Paid	4.3b	4.8b	4.0b

JPY	FY, 2018
Revenue/Employee	14.0m
Debt/Equity	2.8 x
Debt/Assets	0.6 x
Financial Leverage	4.5 x

	Y, 2018	Y, 2019	Y, 2020
Ampoules/Vials Produced		700 m	700 m
Capsules Produced	400 m	400 m	400 m
Dual Chamber Bags Produced	33 m	33 m	33 m
Granules/ Dry Syrups Produced, tons		610	610
Liquid-Liquid Dual Chamber Bags Produced		4 m	4 m
Ointments/Creams Produced, 10g-tubes		16.3 m	16.3 m
Poultices Produced, 10g-sheets	390 m	390 m	390 m
Pre-filled Syringes Produced	160 m	160 m	160 m
Syrups Produced, bottles		460 k	460 k
Tablets Produced	14 b	14.8 b	14.8 b
Tapes Produced (Hotmelt Type), sheets	150 m	580 m	580 m
Tapes Produced (Solvent Type), sheets		120 m	120 m